Stockreport

Medopad rebrands as Huma, acquires BioBeats and TLT to expand its biomarker platform [TechCrunch Blog]

TENCENT HLDGS UNSP/ADR  (TCEHY) 
NASDAQ:AMEX Investor Relations: tencent.com/en-us/investor.html
PDF Some big changes are underway for London-basedMedopadThe company is rebranding toHumaBioBeatsThe financial terms of the deals have not been disclosed but we understand B [Read more]